Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Nov 17 - Nov 22
(PubMed) Lodge JK, Youn HD, Handelman GJ, et al
The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) recommend an A1C level of 6.5% or less for diabetics without concurrent serious illness and low hypoglycemia risk, and a level of about 6.5% - 7% for those with concurrent illnesses or increased hypoglycemia risk (Garber 2020)
Thymosin Alpha-1 has the strongest clinical evidence base of any peptide on the list, with published research in infectious disease support, immune reconstitution, and oncology-adjacent immune modulation
Clinical Gastroenterology and Hepatology
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
